Buy 3-MeO-PCP Quality Drug Online wholesale from the manufacturer, high quality at a low price with shipping worldwide.3MEO PCP with the formal name of 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine is classified as a dissociative compound
3-Methoxyphencyclidine (commonly known as 3-MeO-PCP or 3-MeO) is a lesser-known novel dissociative substance of the arylcyclohexylamine class that produces dissociative, anesthetic, and hallucinogenic effects when administered. It is structurally related to arylcyclohexylamines like PCP, MXE, and 3-MeO-PCE.
3-MeO-PCP was first synthesized in 1979 to investigate the structure-activity relationship of phencyclidine (PCP) derivatives. Its activity in humans was not described until 1999 when a chemist using the pseudonym John Q. Beagle reported qualitative similarities to PCP along with comparable potency.
- Product Name: 3-methoxy PCP (hydrochloride)
- IUPAC Name: 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine, monohydrochloride
- Other Names: 3-MeO PCP, 3-MeO Phencyclidine
- Cas Number: 91164-58-8
- Molecular Formula: C18H27NO • HCl
- Appearance: Crystalline solid and powder
- Application: Research purposes
Like other substances of its class, particularly methoxetamine (MXE), phencyclidine (PCP), and 3-MeO-PCE, it is known to primarily induce a state referred to as “dissociative anesthesia”, although the extent to which this occurs is reported to be highly dose-dependent and variable in its effects. It is commonly taken orally and nasally, although it may also be smoked and injected. It has been noted for its subtle come-up and tendency to produce delusions of sobriety, which can lead to compulsive redosing.
Today, 3-MeO-PCP is rarely sold on the streets and almost exclusively obtained as a gray area research chemical through the use of online vendors, where it is commonly used as a recreational substance and, more rarely and controversially, as an entheogen. Due to its potent dissociative, stimulant, and hallucinogenic effects, commonly reported habit-forming properties, as well an unknown toxicity profile, it is strongly recommended that one use proper harm reduction practices if using this substance.
3-Methoxyphencyclidine, or 3-MeO-PCP, is a synthetic dissociative of the arylcyclohexylamine class. 3-MeO-PCP contains cyclohexane, a six-member saturated ring, bonded to two additional rings at R1. One of these rings is a piperidine ring, a nitrogenous six-member ring, bonded at its nitrogen group. The other ring is an aromatic phenyl ring, substituted at R3 with a methoxy group.
3-MeO-PCP is a PCP derivative and structurally analogous to 3MEO PCP.
3-MeO-PCP acts as an NMDA receptor antagonist. A specific subtype of glutamate receptor, NMDA (N-Methyl-D-Aspartate), modulates the transmission of electrical signals between neurons in the brain and spinal cord; for the signals to pass, the receptor must be open.
Dissociatives inhibit the normal functioning NMDA receptors by binding to and blocking them. This disruption of neural network activity leads to loss of normal cognitive and affective processing, psychomotor functioning, anesthesia, and eventually an almost identical equivalent of the famous “k-hole.”
- Availability: In Stock
- Packaging: Aluminum foil bag package done by expert
- Purity: 99.9%
- Origin: China
- Minimum order: 10 Grams
- Production Capacity: 100KG/WEEK
- Transportation: Delivery done by EMS, DHL, FEDEX, UPS and TNT
Because of its strong dissociative, stimulant, and hallucinogenic outcomes, typically claimed routine-forming properties, as well as unfamiliar toxicity profile, it is strongly encouraged that 1 use the right damage reduction tactics if employing this material.
With a little luck, this will likely produce fewer stimulation and mania, and as a consequence much less from the outrageous feats, the PCP is infamous for.
Fantastic, I’m happy to listen to you like it! The channel issue caught me off guard, but we’re only 24 hrs into This great site and it’s by now turning out to be a favorable action for The Drug Classroom.
The initial mentions of 3MEO PCP seem to have come around mid-2009 which has a couple of experiences scattered all over. Interest appeared to be piqued yet again as MXE received popularity, but its increase continues to be stunted intentionally by accountable vendors making certain It’s not quickly accessed. Presented the incidents we have been presently seeing with other preferred, strong drugs, this appears to be practical.